A comprehensive set of risk groups explicitly identifies groups of individuals with multiple interacting co-morbid conditions, and which explicitly identifies the severity of illness level. This allows accurate prediction of future health care resource needs of an entire population, while simultaneously helping the health care provider isolate problems to identify changes in care to reduce costs and improve quality.

 
Web www.patentalert.com

< Glucagon-like peptide-1 analogs

< DB, the receptor for leptin

> Protein kinase and phosphatase inhibitors and methods for designing them

> Method of systematically delivering SSRIs

~ 00297